The Journal of Heart and Lung Transplantation
Volume 24, Issue 10 , Pages 1489-1500 , October 2005

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part VI: Treatment

  • Yaron Shargall, MD

      Affiliations

    • Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada
    • ,
  • Grisha Guenther, MD

      Affiliations

    • Deutsches Herzzentrum, Berlin, Germany
    • ,
  • Vivek N. Ahya, MD

      Affiliations

    • School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Abbas Ardehali, MD

      Affiliations

    • University of California at Los Angeles, Los Angeles, California
    • ,
  • Arun Singhal, MD

      Affiliations

    • School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Shaf Keshavjee, MD (FRCSC)

      Affiliations

    • Division of Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Shaf Keshavjee, MD, Division of Thoracic Surgery, Toronto General Hospital, 200 Elizabeth St 9N-946 Toronto, ON, Canada M592C4. Tel (416) 340 4010.

Received 6 October 2004 ,Revised 23 February 2005 ,Accepted 14 March 2005.

References 

  1. Snell G , Klepetko W . Perioperative lung transplant management . Eur Respir Mon . 2003;26:130–142
  2. Chakinala MM , Kollef MH , Trulock EP . Critical care aspects of lung transplant patients . J Intensive Care Med . 2002;17:8–33
  3. Goudarzi BM , Bonvino S . Critical care issues in lung and heart transplantation . Crit Care Clin . 2003;19:209–231
  4. Christie JD , Kotloff RM , Pochettino A , et al.   Clinical risk factors for primary graft failure following lung transplantation . Chest . 2003;124:1232–1241
  5. Bernard GR , Reines HD , Brigham KL , et al.   The American European consensus conference on ARDS (definitions, mechanism, relevant outcomes and clinical trials coordination) . Am J Respir Crit Care Med . 1994;149:818–824
  6. Marili JJ . Evolving concepts in the ventilatory management of acute respiratory distress syndrome . Clin Chest Med . 1996;17:555–575
  7. Malarkkan N , Snook NJ , Lumb AB . New aspects of ventilation in acute lung injury . Anaesthesia . 2003;58:647–667
  8. Imai Y , Parodo J , Kajikawa O , et al.   Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome . JAMA . 2003;289:2104–2112
  9. Slutsky AS . Basic science in ventilator-induced lung injury (implications for the bedside) . Am J Respir Crit Care Med . 2001;163:599–600
  10. The Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome . N Engl J Med . 2000;342:1301–1308
  11. Kopp R , Kuhlen R , Max M , Rossaint R . Evidence-based medicine in the therapy of the acute respiratory distress syndrome . Intensive Care Med . 2002;28:244–255
  12. Pelosi P , Tubiolo D , Mascheroni D , et al.   Effects of the prone position on respiratory mechanism and gas exchange during acute lung injury . Am J Respir Crit Care Med . 1998;157:387–393
  13. Gattinoni L , Tognoni G , Pesenti A , et al.   Effect of prone positioning on the survival of patients with acute respiratory failure . N Engl J Med . 2001;345:568–573
  14. de Perrot M , Imai Y , Volgyesi GA , et al.   Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model . J Thorac Cardiovasc Surg . 2002;124:1137–1144
  15. Gavazzeni V , Iapichino G , Mascheroni D , et al.   Prolonged independent lung respiratory treatment after single lung transplantation in pulmonary emphysema . Chest . 1993;103:96–100
  16. Popple C , Higgins T , McCarthy P , et al.   Unilateral auto-PEEP in the recipient of a single lung transplant . Chest . 1993;103:297–299
  17. Officer TM , Wheeler DR , Frost AE , Rodarte JR . Respiratory control during independent lung ventilation . Chest . 2001;120:678–681
  18. Pinsky DJ , Naka Y , Chowdhury NC , et al.   The nitric oxide/cyclic GMP pathway in organ transplantation (critical role in successful lung preservation) . Proc Natl Acad Sci USA . 1994;91:12086–12090
  19. Yamashita MR , Schmid A , Ando K , Cooper JD , Patterson GA . Nitroprusside ameliorates lung allograft reperfusion injury . Ann Thorac Surg . 1996;62:791–796
  20. Bacha EA , Herve P , Murakami S , et al.   Lasting beneficial effect of short term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group . J Thorac Cardiovasc Surg . 1996;112:590–598
  21. Naka YN , Chowdhury NC , Ox MC , et al.   Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model . J Thorac Cardiovasc Surg . 1995;109:206–210
  22. Bacha EA , Sellak H , Murakami S , et al.   Inhaled nitric oxide attenuates reperfusion injury in non-heart beating-donor lung transplantation. Paris-Sud University Lung Transplantation Group . Transplantation . 1997;63:1380–1386
  23. Karamsetty MR , Klinger JR . NO (more than just a vasodilator in lung transplantation) . Am J Respir Cell Mol Biol . 2002;26:1–5
  24. Ricagna F , Miller VM , Tazelaar HD , McGregor CG . Endothelin-1 and cell proliferation in lung organ cultures (implications for lung allografts) . Transplantation . 1996;62:1492–1498
  25. Minamoto K , Pinsky DJ , Fuijita T , Naka Y . Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation . Am J Respir Cell Mol Biol . 2002;26:14–21
  26. Bhabra MS , Hopkinson DN , Shaw TE , Hooper TL . Low dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function . Ann Thorac Surg . 1997;63:339–344
  27. Struber M , Harringer W , Ernest M , et al.   Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung . Thorac Cardiovasc Surg . 1999;47:179–182
  28. Meade MO , Granton JT , Matte-Martyn A , et al.   A randomized trial of inhaled nitric oxide to prevent ischemia–reperfusion injury after lung transplantation . Am J Respir Crit Care Med . 2003;167:1483–1489
  29. Ardehali A , Laks H , Levine M , et al.   A prospective trail of inhaled nitric oxide in clinical lung transplantation . Transplantation . 2001;72:112–115
  30. Cornfield DN , Milla CE , Hadda IY , Barbato JE , Park SJ . Safety of inhaled nitric oxide after lung transplantation . J Heart Lung Transplant . 2003;22:903–907
  31. Date H , Triantafillou AN , Trulock EP , et al.   Inhaled nitric oxide reduces human lung allograft dysfunction . J Thorac Cardiovasc Surg . 1996;111:913–919
  32. Adatia I , Lillehei C , Arnold JH , et al.   Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation . Ann Thorac Surg . 1994;57:1311–1318
  33. MacDonald P , Mundy J , Rogers P , et al.   Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide . J Thorac Cardiovasc Surg . 1995;110:861–863
  34. Garat C , Jayr C , Eddahibi S , et al.   Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hypoxic lung injury . Am J Respir Crit Care Med . 1997;155:1957–1964
  35. Taylor RW , Zimmerman JL , Dellinger RP , et al.   Low-dose inhaled nitric oxide in patients with acute lung injury . JAMA . 2004;291:1603–1609
  36. Sokol J , Jacobs SF , Bohn D . Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults . Cochrane Database Syst Rev . 2003; CD002787
  37. Vainikka TL , Heikkila LJ , Kukkonen S , Toivonen HJ . Inhaled NO and prostacyclin during porcine single lung transplantation . Ann Thorac Surg . 2001;72:1892–1897
  38. Murakami S , Bacha EA , Mazmanian GM , et al.   Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia–reperfusion (the Paris-Sud University Lung Transplantation Group) . Am J Respir Crit Care Med . 1997;156:454–458
  39. Lavoie A , Hall JB , Olson DM , Wylam ME . Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure . Am J Respir Crit Care Med . 1996;153:1985–1987
  40. Eppinger MJ , Ward PA , Jones ML , Bolling SF , Deeb GM . Disparate effects of nitric oxide on lung ischemia–reperfusion injury . Ann Thorac Surg . 1995;60:1169–1176
  41. Chiang CH , Wu K , Yu CP , et al.   Protective agents used as additives in University of Wisconsin solution to promote protection against ischaemia–reperfusion injury in rat lung . Clin Sci (Lond) . 1998;95:369–376
  42. Chiang CH , Wu K , Yu CP , et al.   Hypothermia and prostaglandin E(1) produce synergistic attenuation of ischemia–reperfusion lung injury . Am J Respir Crit Care Med . 1999;160:1319–1323
  43. Naka Y , Roy DK , Liao H , et al.   cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation . Circ Res . 1996;79:773–783
  44. Levin G , Duffin KL , Obukowicz MG , et al.   Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2 (implications for cellular synthesis of prostaglandin E1 and prostaglandin E2) . Biochem J . 2002;365:489–496
  45. Aoe M , Trachiotis GD , Okabayashi K , et al.   Administration of prostaglandin E1 after lung transplantation improves early graft function . Ann Thorac Surg . 1994;58:655–661
  46. DeCampos KN , Keshavjee S , Liu M , Slutsky AS . Prevention of rapid reperfusion-induced lung injury with prostaglandin E1 during the initial period of reperfusion . J Heart Lung Transplant . 1998;17:1121–1128
  47. Matsuzaki Y , Waddell TK , Puskas JD , et al.   Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1 . Am Rev Respir Dis . 1993;148:882–889
  48. de Perrot M , Fischer S , Liu M , et al.   Prostaglandin E1 protects lung transplants from ischemia–reperfusion injury (a shift from pro- to anti-inflammatory cytokines) . Transplantation . 2001;72:1505–1512
  49. Okada Y , Marchevsky AM , Zuo XJ , et al.   Accumulation of platelets in rat syngeneic lung transplants (a potential factor responsible for preservation–reperfusion injury) . Transplantation . 1997;64:801–806
  50. Koga T , Az-ma T , Yuge O . Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells . Acta Anaesthesiol Scand . 2002;46:987–993
  51. Okada Y , Marchevsky AM , Kass RM , Matloff JM , Jordan SC . A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation–reperfusion injury of isografts in a rat model of lung transplantation . Transplantation . 1998;66:1132–1136
  52. Fiser SM , Cope JT , Kron IL , et al.   Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation . J Thorac Cardiovasc Surg . 2001;121:981–982
  53. Schutte H , Lockinger A , Seeger W , Grimminger F . Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia–reperfusion . Eur Respir J . 2001;18:15–22
  54. Schutte H , Schell A , Schafer C , et al.   Subthreshold doses of nebulized prostacyclin and rolipram synergistically protect against lung ischemia–reperfusion . Transplantation . 2003;75:814–821
  55. Weaver TE , Whitsett JA . Structure and function of pulmonary surfactant proteins . Semin Perinatol . 1988;12:213–220
  56. Novick RJ , Possmeyer F , Veldhuizen RAW , et al.   Surfactant analysis and replacement therapy (a future tool of the lung transplant surgeon?) . Ann Thorac Surg . 1991;52:1194–1200
  57. King JR . Pulmonary surfactant . J Appl Physiol . 1982;53:1–8
  58. Ochs M , Nenadic I , Fehrenbach A , et al.   Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion . Am J Respir Crit Care Med . 1999;160:718–724
  59. Waldhausen JA , Giammona ST , Kilmann JW , et al.   Effect of transplantation of canine lung on pulmonary compliance and surfactant . JAMA . 1965;191:1002–1005
  60. Andrade R , Solien EE , Wangensteen OD . Surfactant dysfunction in lung preservation . Transplantation . 1995;60:536–541
  61. Hohlfeld JM , Tiryaki E , Hamm H , et al.   Pulmonary surfactant activity is impaired in lung transplant recipients . Am J Respir Crit Care Med . 1998;158:706–712
  62. Ochs M , Fehrenbach H , Nenadic I , et al.   Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model . Eur Respir J . 2000;15:526–531
  63. Veldhuizen RA , Lee J , Sandler D , et al.   Alterations in pulmonary surfactant composition and activity after experimental lung transplantation . Am Rev Respir Dis . 1993;148:208–215
  64. Novick RJ , Veldhuizen RA , Possmayer F , et al.   Exogenous surfactant therapy in thirty-eight hour lung graft preservation for lung transplantation . J Thorac Cardiovasc Surg . 1994;108:259–268
  65. Maitra G , Inchley K , Novick RJ , et al.   Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant . Am J Physiol Lung Cell Mol Physiol . 2002;282:L67–L74
  66. Novick RJ , Gilpin AA , Gehman KE , et al.   Mitigation of injury in canine lung grafts by exogenous surfactant therapy . J Thorac Cardiovasc Surg . 1997;113:342–353
  67. Hohlfeld JM , Struber M , Ahlf K , et al.   Exogenous surfactant improves survival and surfactant function in ischaemia–reperfusion injury in minipigs . Eur Respir J . 1999;5:1037–1043
  68. Erasmus ME , Hofstede GJ , Petersen AH , et al.   SP-A enriched surfactant for treatment of rat lung transplant with SP-A deficiency after storage and reperfusion . Transplantation . 2002;73:348–352
  69. de Perrot M , Liu M , Wadell TK , Keshavjee S . Ischemia–reperfusion-induced lung injury . Am J Respir Crit Care Med . 2003;167:490–511
  70. Erasmus ME , Petersen AH , Hofstede G , et al.   Surfactant treatment before reperfusion improves immediate function of lung transplants in rats . Am J Respir Crit Care Med . 1996;153:665–670
  71. Hausen B , Rohde R , Hewitt CW , et al.   Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation . J Thorac Cardiovasc Surg . 1997;113:1050–1058
  72. Novick RJ , MacDonald J , Veldhuizen RAW , et al.   Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation . Am J Respir Crit Care Med . 1996;154:98–104
  73. Koletsis E , Chatzimichalis A , Fotopoulos V , et al.   Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology . Exp Biol Med . 2003;228:540–545
  74. Strueber M , Cremer J , Harringer W , et al.   Nebulized synthetic surfactant in reperfusion injury after single lung transplantation . J Thorac Cardiovasc Surg . 1995;110:563–564
  75. Strueber M , Hirt SW , Cremer J , et al.   Surfactant replacement in reperfusion injury after clinical lung transplantation . Intensive Care Med . 1999;25:862–864
  76. Strueber M . What is the role of surfactant and inhaled nitric oxide in lung transplantation? . Crit Care . 2002;6:186–187
  77. Strueber M , Niedermeyer J , Warnecke G , et al.   Exogenous surfactant instillation in lung donors to reduce early graft dysfunction . J Heart Lung Transplant . 2003;22(suppl):S14
  78. Pierre AF , Xavier AM , Liu M , et al.   Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function . Transplantation . 1998;66:723–732
  79. Schmid RA , Zollinger A , Singer T , et al.   Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine . J Thorac Cardiovasc Surg . 1998;116:90–97
  80. Strüber M , Hagl C , Hirt SW , et al.   C1-esterase inhibitor in graft failure after lung transplantation . Intensive Care Med . 1999;25:1315–1318
  81. Zamora MR , Davis RD , Keshavjee SH , et al.   Complement inhibition attenuates human lung transplant reperfusion injury (a multicenter trial) . Chest . 1999;116(suppl):46S
  82. Keshavjee S , Davis RD , Zamora MR , de Perrot M , Patterson GA . A randomized, placebo controlled trial of complement inhibition in ischemia–reperfusion injury after lung transplantation in human beings . J Thorac Cardiovasc Surg . 2005;129:423–428
  83. Wittwer t , Grote M , Oppelt P , et al.   Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation . J Heart Lung Transplant . 2001;20:358–363
  84. Grino JM . BN 52021 (a platelet activating factor antagonist for preventing post-transplant renal failure: a double-blind, randomized study: the BN 52021 study group in renal transplantation) . Ann Intern Med . 1994;121:345–347
  85. Fisher S , Maclean AA , Liu M , Kalirai B , Keshavjee SH . Inhibition of angiotensin-converting enzyme by captopril (a novel approach to reduce ischemia–reperfusion injury after lung transplantation) . J Thorac Cardiovasc Surg . 2000;120:573–580
  86. Salvatierra A , Guerrero R , Rodriguez M , et al.   Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog . Circulation . 2001;104:2975–2980
  87. Soccal PM , Gasche Y , Miniati DN , et al.   Matrix metalloproteinase inhibitor decreases ischemia–reperfusion injury after lung transplantation . Am J Transplant . 2004;4:41–50
  88. Eriksson LT , Steen S . Induced hypothermia in critical respiratory failure after lung transplantation . Ann Thorac Surg . 1998;65:827–829
  89. Eriksson LT , Roscher R , Ingemansson R , Steen S . Cardiovascular effects of induced hypothermia after lung transplantation . Ann Thorac Surg . 1999;67:804–809
  90. Stolar CJH , Snedecor SM , Bartlett RH . Extracorporeal membrane oxygenation and neonatal respiratory failure (experience from the extracorporeal life support organization) . J Pediatr Surg . 1991;26:563–571
  91. Kolla S , Awad SS , Rich PB , et al.   Extracorporeal life support for 100 adult patients with severe respiratory failure . Ann Surg . 1997;226:544–566
  92. Meyers BF , Sundt TM , Henry S , et al.   Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation . J Thorac Cardiovasc Surg . 2000;120:20–26
  93. Fiser SM , Kron IL , Long SM , et al.   Early intervention after severe oxygenation index elevation improves survival following lung transplantation . J Heart Lung Transplant . 2001;20:631–636
  94. Glassman LR , Keenan RJ , Fabrizio MC , et al.   Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients . J Thorac Cardiovasc Surg . 1995;110:723–727
  95. Ball JW , Noon GP , Short HD , Scheinin SA . Extracorporeal membrane oxygenation for early graft dysfunction in lung transplantation (a case report) . J Heart Lung Transplant . 1997;16:468–471
  96. Smedira NG , Moazami N , Golding CM , et al.   Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure (survival at five years) . J Thorac Cardiovasc Surg . 2001;122:92–102
  97. Kato J , Seo T , Ando H , Takagi H , Takahiro I . Coronary arterial perfusion during venoarterial extracorporeal membrane oxygenation . J Thorac Cardiovasc Surg . 1996;111:630–636
  98. Sekela ME , Noon GP , Holland VA , Lawrence EC . Differential perfusion (potential complication of femoral–femoral bypass during lung transplantation) . J Heart Lung Transplant . 1991;10:322–324
  99. Pereszlenyi A , Lang G , Steltzer H , et al.   Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension . Eur J Cardio-thorac Surg . 2002;21:858–863
  100. Nelems JM , Duffin J , Glynn MFX , et al.   Extracorporeal membrane oxygenator support for human lung transplantation . J Thorac Cardiovasc Surg . 1978;76:28–32
  101. Jurmann MJ , Haverich A , Demertzis S , et al.   Extracorporeal membrane oxygenation (ECMO) (extended indications for artificial support of both heart and lungs) . Int J Artif Org . 1991;14:771–774
  102. Zenati M , Pham SM , Keenan RJ , Griffith BP . Extracorporeal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction . Transplant Int . 1996;9:227–230
  103. Nguyen DQ , Kulick DM , Bolman RM , et al.   Temporary ECMO support following lung and heart–lung transplantation . J Heart Lung Transplant . 2000;19:313–316
  104. Horowitz JH , Carrico CJ , Shires T . Pulmonary response to major injury . Arch Surg . 1974;108:349–355
  105. Ko WJ , Chen YS , Luh SP , Chu SH . Extracorporeal membrane oxygenation support for single-lung transplantation in patients with primary pulmonary hypertension . Transplant Proc . 1999;31:166–168
  106. Ko WJ , Chen YS , Lee YC . Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations . Artif Organs . 2001;25:607–612
  107. Dahlberg PS , Prekker ME , Hertz MI , Herrington CS , Park SJ . Medium term results of ECMO for severe acute lung injury following lung transplantation . J Heart Lung Transplant . 2003;22(suppl 1):S159–S160
  108. Trulock EP , Edwards LB , Taylor DO , et al.   The registry of the International Society for Heart and Lung Transplantation (twentieth official adult lung and heart–lung transplant report—2003) . J Heart Lung Transplant . 2003;22:625–635
  109. Wekerle T , Klepetko W , Wisser W , et al.   Lung retransplantation (institutional report on a series of twenty patients) . J Heart Lung Transplant . 1996;15:182–189
  110. Schäfers HJ , Hausen B , Wahlers T , et al.   Retransplantation of the lung. A single center experience . Eur J Cardiothorac Surg . 1995;9:291–296
  111. Haverich A , Hirt SW , Wahlers T , et al.   Functional results after lung retransplantation . J Heart Lung Transplant . 1994;13:48–55
  112. Novick RJ , Stitt L . Pulmonary retransplantation . Semin Thorac Cardiovasc Surg . 1998;10:227–236
  113. Novick RJ , Stitt LW , Al Kattan K , et al.   Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry . Ann Thorac Surg . 1998;65:227–234
  114. Novick RJ , Stitt L , Schafers HJ , et al.   Pulmonary retransplantation (does the indication for operation influence postoperative lung function?) . J Thorac Cardiovasc Surg . 1996;112:1504–1513
  115. Novick RJ , Schafers HJ , Stitt L , et al.   Seventy-two pulmonary re-transplantations for obliterative bronchiolitis (predictors of survival) . Ann Thorac Surg . 1995;60:111–116
  116. Novick RJ , Kaye MP , Patterson GA , et al.   Redo lung transplantation (a North American–European experience) . J Heart Lung Transplant . 1993;12:5–16
  117. Novick RJ , Schäfers HJ , Stitt L , et al.   Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients . J Thorac Cardiovasc Surg . 1995;110:1402–1414

PII: S1053-2498(05)00195-6

doi: 10.1016/j.healun.2005.03.011

The Journal of Heart and Lung Transplantation
Volume 24, Issue 10 , Pages 1489-1500 , October 2005

Article Tools